Prolonged Anticoagulation During Eighteen Months vs. Placebo After Initial Six-Month Treatment for a First Episode of Idiopathic Pulmonary Embolism - PADIS-PE

Description:

The goal of this trial was to assess safety and efficacy of extended duration of anticoagulation—an additional 18 months beyond the planned initial 6-month duration—in patients with a first episode of idiopathic pulmonary embolism (PE).

Contribution to the Literature: The PADIS-PE trial shows that extended duration of anticoagulation is beneficial in patients with a first episode of idiopathic PE.